The Benefit of Implementing a Heart Failure Disease Management Program | Zendy

David J. Whellan | Zendy; Laura Gaulden | Zendy; Wendy A. Gattis | Zendy; Bradi B. Granger | Zendy; Stuart D. Russell | Zendy; Michael A. Blazing | Zendy; Michael S. Cuffe | Zendy; Christopher M. O’Connor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Benefit of Implementing a Heart Failure Disease Management Program

Author(s) -

David J. Whellan,

Laura Gaulden,

Wendy A. Gattis,

Bradi B. Granger,

Stuart D. Russell,

Michael A. Blazing,

Michael S. Cuffe,

Christopher M. O’Connor

Publication year - 2001

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.161.18.2223

Subject(s) - medicine , heart failure , ejection fraction , disease management , dosing , health care , disease , emergency medicine , beta blocker , intensive care medicine , cardiology , parkinson's disease , economics , economic growth

To handle the increasing complexity of congestive heart failure (CHF) care, several new models for the care of patients with CHF have been developed to replace traditional strategies. We undertook this study to evaluate the potential benefit of implementing a CHF disease management program at a tertiary care center, particularly in terms of beta-blocker use and cost to the health care system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research